This document provides an introduction to infectious diseases. It defines key terms like disease, infection, pathogen, and host. It describes Koch's postulates for determining the causative agent of a disease. The main types of infectious disease agents are described as bacteria, viruses, protozoa, fungi, and helminths. Examples are given of historic pandemics and how infectious agents cause disease. The phases of infectious disease are outlined. Diseases are also classified by duration, location, and timing of infection. Influenza is presented as an example disease. Ways that diseases spread and can be prevented are discussed. The impact of infectious diseases on mortality is addressed, as are emerging infectious diseases and factors influencing transmission.
It gives all the important definitions used in infectious disease epidemiology and continues to elaborate on dynamics of disease transmission followed by prevention and control of infectious diseases.
this presentation tells u all about the infectious diseases..their causes.............and how they are transmitted...............so i hope that it will be very knowledgeable for u all.......
meaning...classification...examples...causes....indications of endemic diseases. It provides general information as per the teaching materials for teachers
It gives all the important definitions used in infectious disease epidemiology and continues to elaborate on dynamics of disease transmission followed by prevention and control of infectious diseases.
this presentation tells u all about the infectious diseases..their causes.............and how they are transmitted...............so i hope that it will be very knowledgeable for u all.......
meaning...classification...examples...causes....indications of endemic diseases. It provides general information as per the teaching materials for teachers
Microbe-Human Interactions: Infection and DiseaseMELVIN FAILAGAO
Chapter 12 Microbe-Human Interactions: Infection and Disease
subtopics:
1. The progress of an infection
2. Epidemiology: The study of disease in Populations
3. Non specific host defenses
4. Defense mechanisms of the host in perspective
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
5. Infectious Diseases - Definitions
Disease - a pathological condition of body parts or
tissues characterized by an identifiable group of
signs and symptoms.
Infectious disease - disease caused by an
infectious agent such as a bacterium, virus,
protozoan, or fungus that can be passed on to
others.
Infection - occurs when an infectious agent enters
the body and begins to reproduce; may or may not
lead to disease.
Pathogen - an infectious agent that causes disease.
Host - an organism infected by another organism.
Virulence - the relative ability of an agent to cause
rapid and severe disease in a host.
6. Koch’s Postulates
Koch developed four criteria to demon-
strate that a specific disease is caused
a particular agent.
1. The specific agent must be associated
with every case of the disease.
2. The agent must be isolated from a diseased host
and grown in culture.
3. When the culture-grown agent is introduced
into a healthy susceptible host, the agent must
cause the same disease.
4. The same agent must again be isolated from the
infected experimental host.
Robin Cochran-Dirksen (Many slides from
BioEdOnline Baylor Christine Herrmann PhD)
8. Infectious Disease Agents
Most infectious agents that cause
disease are microscopic in size and thus,
are called microbes or microorganisms.
Different groups of agents that cause
disease are:
Bacteria
Viruses
Protozoa (Protists)
Fungi
Helminths (Animals)
9. Infectious Diseases Throughout
History
Infectious agents have probably always caused
disease in humans.
Smallpox has been described in ancient
Egyptian and Chinese writings and may have
been responsible for more deaths than all other
infectious diseases combined.
There is evidence that malaria and
poliomyelitis have existed since ancient times.
In the 14th Century, the bubonic plague, or Black
Death, killed about 20 million people in Europe
alone.
In the 20th Century, the 1918 influenza may have
killed up to 50 million people worldwide
Courtesy of CDC
Recreated 1918
Influenza virions.
The 1918 Spanish
flu killed more than
500,000 people in
the United States
and up to 50 million
worldwide.
Close to 20 million people have died of AIDS to
date.
10.
11.
12.
13.
14.
15. How Infectious Agents Cause
Disease
Production of poisons, such
as toxins and enzymes, that
destroy cells and tissues.
Direct invasion and
destruction of host cells.
Triggering responses from the
host’s immune system
leading to disease signs and
symptoms.
Courtesy of CDC
Human Immunodeficiency
Virus. HIV-1 virions can
be seen on surface of
lymphocytes.
16. Phases of Infectious Disease
Incubation period - time between infection
and the appearance of signs and symptoms.
Prodromal phase - mild, nonspecific
symptoms that signal onset of some diseases.
Clinical phase - a person experiences typical
signs and symptoms of disease.
Decline phase - subsidence of symptoms.
Recovery phase - symptoms have
disappeared, tissues heal, and the body
regains strength.
Robin Cochran-Dirksen (Many slides from BioEdOnline Baylor Christine Herrmann
PhD)
17. Classification of Infectious
Disease
By duration
Acute - develops and runs its course quickly.
Chronic - develops more slowly and is usually less severe, but
may persist for a long, indefinite period of time.
Latent - characterized by periods of no symptoms between
outbreaks of illness.
By location
Local - confined to a specific area of the body.
Systemic - a generalized illness that infects most of the body
with pathogens distributed widely in tissues.
By timing
Primary - initial infection in a previously healthy person.
Secondary - infection that occurs in a person weakened by a
primary infection.
19. Example of an Infectious Disease -
Flu
Acute contagious disease caused by the
influenza virus.
Respiratory tract infection, but symptoms felt
throughout entire body.
Epidemics occur seasonally with low fatality;
more deadly pandemics occur several times each
century.
Highly changeable virus that can infect multiple
species, including humans, pigs, and birds.
Concern exists that current avian flu will lead to
a new pandemic.
20. Transmission of Infectious
Diseases
Agents that cause infectious diseases
can be transmitted in many ways.
Through the air
Through contaminated food or w
Through body fluids
By direct contact
with contaminated objects
By animal vectors such
as insects, birds, bats, etc.
Aedes aegypti mosquito
Known to transmit
Dengue fever
21. Reducing the Spread of
Infectious Diseases
Vaccines
Antimicrobial drugs
Good personal hygiene
and sanitation
Protection against mosquitoes
Quarantine
Robin Cochran-Dirksen (Many slides from BioEdOnline Baylor Christine Herrmann
PhD)
22. Infectious Diseases as a Cause
of Death
Infectious diseases are responsible for a quarter to a
third of all deaths worldwide.
Infectious diseases account for more than half of all
deaths in children under the age of 5.
Of the top ten causes of death compiled by the World
Health Organization, five are due to infectious diseases.
The top single agent killers are HIV/AIDS, malaria and
tuberculosis. The other top killers are lower respiratory
infections and diarrheal diseases, which are caused by a
variety of agents.
23. Emerging Infectious Diseases
Emerging diseases are those that have
recently appeared within a population, or
whose incidence or geographic range is
increasing rapidly.
Diseases can emerge or re-emerge due to:
appearance of a previously unknown
agent.
evolution of a new infectious agent.
spread of an infectious agent to a new
host.
spread of an infectious agent to new
locations.
acquisition of resistance to anti
microbial drugs.